| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0928-8244(02)00442-X |
| P698 | PubMed publication ID | 12628542 |
| P50 | author | Peter Vandamme | Q21337596 |
| P2093 | author name string | Dervla T Kenna | |
| John R W Govan | |||
| Ross J Langley | |||
| Victoria A Barcus | |||
| P2860 | cites work | Burkholderia cepacia complex infection in patients with cystic fibrosis | Q30705619 |
| Identification and population structure of Burkholderia stabilis sp. nov. (formerly Burkholderia cepacia genomovar IV). | Q33179898 | ||
| Serotype-converting bacteriophages and O-antigen modification in Shigella flexneri | Q33818885 | ||
| Burkholderia cepacia complex bacteria from clinical and environmental sources in Italy: genomovar status and distribution of traits related to virulence and transmissibility | Q33952104 | ||
| Outbreak of subclinical mastitis in a flock of dairy sheep associated with Burkholderia cepacia complex infection. | Q33971552 | ||
| Burkholderia cepacia complex infection in Italian patients with cystic fibrosis: prevalence, epidemiology, and genomovar status | Q33973155 | ||
| Taxonomy and identification of the Burkholderia cepacia complex | Q33973532 | ||
| Diversity of the Burkholderia cepacia complex and implications for risk assessment of biological control strains | Q34433607 | ||
| O-antigen structural variation: mechanisms and possible roles in animal/plant-microbe interactions | Q34635579 | ||
| A fusion promoter created by a new insertion sequence, IS1490, activates transcription of 2,4,5-trichlorophenoxyacetic acid catabolic genes in Burkholderia cepacia AC1100 | Q35622307 | ||
| Epidemiology of Burkholderia cepacia complex in patients with cystic fibrosis, Canada | Q36014916 | ||
| Role of the rfaG and rfaP genes in determining the lipopolysaccharide core structure and cell surface properties of Escherichia coli K-12 | Q36110925 | ||
| Heterogeneity of Rhizobium lipopolysaccharides | Q36300819 | ||
| O and H serotyping of Pseudomonas cepacia | Q37257397 | ||
| Lysogenic conversion in Pseudomonas aeruginosa. | Q37428721 | ||
| Identification of the lipopolysaccharide core region as the receptor site for a cytotoxin-converting phage, phi CTX, of Pseudomonas aeruginosa | Q38304663 | ||
| The chemical structure of bacterial endotoxin in relation to bioactivity | Q38320636 | ||
| Genetic variation at the O-antigen biosynthetic locus in Pseudomonas aeruginosa | Q39679452 | ||
| Burkholderia thailandensis E125 harbors a temperate bacteriophage specific for Burkholderia mallei. | Q39679646 | ||
| Priming of neutrophil respiratory burst activity by lipopolysaccharide from Burkholderia cepacia. | Q39831246 | ||
| Burkholderia cepacia: medical, taxonomic and ecological issues | Q41260421 | ||
| Pseudomonas cepacia typing systems: collaborative study to assess their potential in epidemiologic investigations. | Q44831840 | ||
| IS406 and IS407, two gene-activating insertion sequences from Pseudomonas cepacia | Q48213967 | ||
| Burkholderia cepacia. Management issues and new insights | Q48766893 | ||
| Characterization of bacteriophage CP1, an organic solvent sensitive phage associated with Pseudomonas cepacia | Q52704491 | ||
| Infection withBurkholderia cepaciaComplex Genomovars in Patients with Cystic Fibrosis: Virulent Transmissible Strains of Genomovar III Can ReplaceBurkholderia multivorans | Q57265587 | ||
| Lung transplantation for cystic fibrosis patients with Burkholderia cepacia complex. Survival linked to genomovar type | Q64449533 | ||
| Type characterisation and antibiotic susceptibility of Burkholderia (Pseudomonas) cepacia isolates from patients with cystic fibrosis in the United Kingdom and the Republic of Ireland | Q71093436 | ||
| Disproportionate distribution of Burkholderia cepacia complex species and transmissibility markers in cystic fibrosis | Q74129572 | ||
| Lipopolysaccharide chemotypes of Burkholderia cepacia | Q78245629 | ||
| P433 | issue | 2 | |
| P921 | main subject | Burkholderia cepacia | Q139227 |
| bacteriophage | Q165028 | ||
| P304 | page(s) | 87-92 | |
| P577 | publication date | 2003-03-01 | |
| P1433 | published in | FEMS Immunology and Medical Microbiology | Q15767550 |
| P1476 | title | Lack of correlation between O-serotype, bacteriophage susceptibility and genomovar status in the Burkholderia cepacia complex | |
| P478 | volume | 35 |
| Q40573648 | Burkholderia cenocepacia lipopolysaccharide, lipid A, and proinflammatory activity. |
| Q37194242 | Chemical and biological features of Burkholderia cepacia complex lipopolysaccharides |
| Q30434471 | Correlation of wbiI genotype, serotype, and isolate source within species of the Burkholderia cepacia complex |
| Q33910553 | Exploring the metabolic network of the epidemic pathogen Burkholderia cenocepacia J2315 via genome-scale reconstruction |
| Q33920487 | Identification of Burkholderia cepacia complex bacteria with a lipopolysaccharide-specific monoclonal antibody |
| Q36118037 | Role of phages in the pathogenesis of Burkholderia, or 'Where are the toxin genes in Burkholderia phages?'. |
| Q21131311 | The promise of bacteriophage therapy for Burkholderia cepacia complex respiratory infections |
Search more.